Welcome to MyStrategist, an online experience like no other in the medical device industry.

MedTech Strategist's complimentary Community Blog focuses on the people and the passion behind the global device space. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.  Trial today to unlock our subscriber-only content.

e-Newsletter   Browse
Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.


Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.


Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.


Coronavirus Analysis

Deloitte: The Post-COVID-19 Shutdown Rebound: How Medtech Companies Can Help Support Deferred Care and Procedure Recovery

The COVID-19 pandemic is testing medical technology companies’ ability to flex operations and help healthcare providers manage demand surges arising from the resumption of deferred care and procedures. To help support the rebound—and prepare for COVID-19’s potential long-term impacts on product, supply chain, and ecosystem capabilities—organizations should rethink their short- and long-term commercial effectiveness strategies. By Doug Billings, Deloitte Consulting LLP.

Subscribe now to read the full analysis

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Coronavirus Analysis

Deloitte: The Post-COVID-19 Shutdown Rebound: How Medtech Companies Can Help Support Deferred Care and Procedure Recovery

The COVID-19 pandemic is testing medical technology companies’ ability to flex operations and help healthcare providers manage demand surges arising from the resumption of deferred care and procedures. To help support the rebound—and prepare for COVID-19’s potential long-term impacts on product, supply chain, and ecosystem capabilities—organizations should rethink their short- and long-term commercial effectiveness strategies. By Doug Billings, Deloitte Consulting LLP.

Subscribe now to read the full analysis

Registration is now open for the 7th annual Innovation Summit Dublin, September 7-9, 2020. The industry's most anticipated event will sell out. Register Today.

Register   Learn More
More From Community Blog:

COVID-19 MedTech Digest, April 16, 2020

Excerpts from the latest coronavirus analysis in MedTech Strategist, Market Pathways, and the Community Blog. Our coronavirus coverage is free to all—click the links to read full articles

Read Article